Skip to main content
. Author manuscript; available in PMC: 2015 Dec 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2014 May 9;12(12):2113–2120.e3. doi: 10.1016/j.cgh.2014.04.037

Table 4.

Markers associated with Change in HAI or Fibrosis Stage in Paired Biopsies from Training cohort.

Type Biomarker Williams Statistic p-value Marker Direction
HAI Change ALT (IU/L) 3.5762 0.0003 Increase
HAI Change GGT (IU/L) 3.4724 0.0004 Increase
HAI Change HA (ng/ ml) 1.7823 0.0470 Increase
HAI Change ICAM1 2.3291 0.0124 Increase
HAI Change IL4 1.7597 0.0493 Increase
HAI Change CXCL10 2.5376 0.0071 Increase
HAI Change CXCL9 2.8528 0.0028 Increase
HAI Change PAI-1 1.9754 0.0302 Decrease
HAI Change VCAM1 (pg/ ml) 2.9859 0.0019 Increase
Fibrosis Change GMCSF (pg/ml) 1.8325 0.0419 Decrease
Fibrosis Change IL12p70 (pg/ml) 3.0888 0.0013 Decrease
Fibrosis Change IL2 (pg/ml) 2.3697 0.0111 Decrease
Fibrosis Change MMP13 (pg/ml) 2.0962 0.0225 Decrease

HAI change indicates ± 2 Histologic necroinflammatory activity score;

Fibrosis change indicates ± 1 METAVIR fibrosis stage